Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
A research study of an approved drug called Heptral®, ademetionine, to treat adults with
intrahepatic cholestasis (a condition where bile cannot flow from the liver to the duodenum)
in pre-cirrhotic and cirrhotic states. Experience from clinical studies in subjects with
liver disease has shown that ademetionine is effective.